In support of our findings regarding the clinical significance for PVR and PVRL2 expression in AML, in pancreatic cancer patients, a high PVR expression also represented an independent prognostic factor for overall survival [20]. This evidence concerns the gene NECTIN2 and familial pancreatic carcinoma.